Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.
The polyene antibiotic amphotericin B is currently a second-line treatment for visceral leishmaniasis (VL) and mucocutaneous leishmaniasis. Lipid-amphotericin B formulations with lower toxicity than the parent drug that were developed for the treatment of systemic mycoses have proved to be an effect...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1997
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163788/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9087483/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.4.752 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|